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Simple Summary: Carbon dioxide and isoflurane are gases with anesthetic properties that are
commonly used in laboratory rodents, especially when anesthetic overdose is used for euthanasia
procedures. Concerns have been raised with the use of carbon dioxide as a euthanasia agent due
to behavioral responses that indicate potential distress. This study was designed to assess aversive
responses in experimentally naïve Sprague–Dawley rats when exposed to isoflurane or carbon
dioxide. When placed in the forced exposure apparatus, these naïve rats were more active in the
isoflurane and CO2 treatments compared to the control groups, suggesting that isoflurane and CO2
are similarly aversive. The results from the aversion-avoidance experiment supported previous work
which demonstrated that while CO2 is more aversive than isoflurane on initial exposure, rats showed
increased aversion when the isoflurane exposure was repeated. We also show that learned aversion
to isoflurane is sustained for at least 15 days after initial exposure. Given this result, we suggest that
CO2 is superior to isoflurane when euthanizing rodents with prior exposure to isoflurane. Overall,
these results confirm previous studies which suggest that care should be taken when considering the
serial use of isoflurane as an anesthetic.
Abstract: Euthanasia in rodents is an ongoing topic of debate due to concerns regarding the aversive
nature of gases with anesthetic properties such as carbon dioxide (CO2) and isoflurane. The aim of
this study was to expand upon previously published work evaluating the aversiveness of CO2 by
introducing an isoflurane treatment group in parallel. Aversion was tested using a forced exposure
setup and an aversion-avoidance setup. In the first part of the study, 12 naïve female Sprague–Dawley
rats were exposed during four consecutive days, once to each of four treatments: isoflurane, fox urine,
oxygen, and CO2. In the second part of the study, 24 naïve female Sprague–Dawley rats and 12 rats
from the first experiment were exposed to CO2, isoflurane, or both gases. In the forced exposure
study, there were no significant differences between CO2 and isoflurane treatments except in line
crosses. Overall, rats were more active in the isoflurane and CO2 treatments compared to the control
groups, suggesting that isoflurane and CO2 are similarly aversive. In the aversion-avoidance study,
rats previously exposed to isoflurane left the dark chamber significantly earlier compared to naïve
rats during exposure to isoflurane. We also show that learned aversion to isoflurane is sustained for
at least 15 days after initial exposure. Given this result, we suggest that CO2 is superior to isoflurane
when euthanizing rodents with prior exposure to isoflurane. Overall, these results confirm previous
studies which suggest that care should be taken when considering the serial use of isoflurane as
an anesthetic.
Keywords: rat; isoflurane; carbon dioxide; aversion
Animals 2020, 10, 1431; doi:10.3390/ani10081431 www.mdpi.com/journal/animals
Animals 2020, 10, 1431 2 of 18
1. Introduction
The appropriate use of inhalant anesthetic gases, such as carbon dioxide (CO2) and isoflurane,
for anesthetic overdose during euthanasia in rodents is an ongoing topic of debate due to concerns
regarding the aversive nature of both of these gases [1,2]. Many studies have focused on CO2 and have
suggested the existence of negative effects of CO2 euthanasia [3–13] while others have contradicted
these claims [1,11,14–19]. There is also variability in euthanasia practices by region to comply with
geographic guidelines. For example, the Canadian Council on Animal Care (CCAC) recommends the
use of inhalant anesthetics followed by a secondary method of euthanasia [20]. Euthanasia using CO2
in rodents is listed as a “conditionally acceptable method” and described as “not an ideal method
of euthanasia” by the CCAC. However, when necessary, the CCAC recommends a gradual-fill rate
between 20–30% chamber volume per minute. This contrasts with recent guidelines published by the
American Veterinary Medical Association (AVMA) that recommends a 30–70% chamber volume per
minute displacement for CO2 euthanasia [21].
Various studies [7,9,10,12,13] have investigated the effect of CO2 on rat behavior and concluded
that CO2 is an aversive agent. This led to the argument that using halogenated inhalant anesthetics
prior to the use of CO2 may be a refinement in euthanasia practices. Coenen et al. [12] used four
methods (pre-fill, high flow rate, low flow rate, and a mixture of CO2 and O2) of CO2 euthanasia
to determine their effects on rat behavior, brain activity, and heart rate. The authors observed high
behavioral agitation and asphyxia in the pre-filled chamber condition, which is consistent with
other studies [4,7–10]. They also noted lower levels of these behaviors in the high flow rate and
low flow rate conditions. However, some authors [2,7] advocate against higher flow rates, so the
study by Coenen et al. [12] added to the growing literature on this controversial topic of discussion.
One controversial observation in this study is the absence of agitation and asphyxia with the mixture of
CO2 and O2, which has been contradicted in various studies [8,15,22] since then. Another study by Niel
and Weary [7] investigated the effect of CO2 gradual-fill of a 17.25% chamber volume displacement
rate during CO2 euthanasia on behavior by dividing the gas exposure period into shorter segments.
They observed an increase in escape behaviors and vocalizations, which are consistent with the
observations by Coenen et al. [12]. The negative effects of CO2 exposure were also illustrated in the
study by Leach et al. [9], who investigated the degree of aversion of rats and mice to CO2, argon,
and CO2–argon mixtures. The authors observed higher aversion to CO2 and CO2–argon mixtures
compared to argon alone based on the initial withdrawal and total dwelling times. However, they did
not observe any significant difference in aversion-associated behaviors during CO2 exposure except
for grooming behaviors.
As has been done extensively for CO2, studies have investigated the effect of isoflurane on
behavior and reported an effect of learned aversion [13,23–25]. In Wong, Makowska, and Weary [23],
the authors investigated total dwelling time in a light–dark apparatus. They observed that 10/16 rats
stayed in the dark chamber until recumbent during initial exposure to isoflurane, but only 1/16 rats did
the same during re-exposure to isoflurane. Similarly, Bertolus et al. [24] used an approach-avoidance
test to investigate aversion to isoflurane and found that while 7/18 rats stayed until recumbent during
initial exposure, only 1/16 stayed during re-exposure. The authors concluded that rats find isoflurane
aversive during initial exposure and that this aversion increases on re-exposure to isoflurane. This is
an important consideration because research animals may have been exposed to isoflurane prior to
euthanasia for clinical or research purposes. Consequently, previous exposure to isoflurane could
influence rat welfare during euthanasia procedures because it would be as aversive as using CO2 only.
In this scenario, isoflurane use during euthanasia would not be a refinement over CO2 use during
euthanasia [25]. Makowska and Weary [25] performed a similar experiment as in Bertolus et al. [24] to
measure aversion to isoflurane. They observed a generalized aversion to isoflurane and halothane on
re-exposure, indicating a component of learned aversion to halogenated anesthetics when previously
exposed. However, the authors recommended the use of halogenated anesthetics as a refinement
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over CO2 despite the effect of learned aversion to isoflurane and their lack of a CO2 treatment group
in parallel.
One critical limitation in these studies that investigate the possible aversive effects of CO2 and
conclude that isoflurane is a refinement over CO2 during euthanasia is a lack of a head-to-head
comparison between CO2 and isoflurane. Therefore, our aim in this study was to investigate the effect
of both CO2 and isoflurane in the forced exposure and aversion-avoidance experimental paradigms
to determine if there was a significant difference between CO2 and isoflurane exposure, with both
previously exposed and naïve rats. In the forced exposure paradigm, we expected that there would be
no significant differences in behavioral responses during CO2 and isoflurane exposure, and that these
responses would be significantly different from control groups. Similarly, in the aversion-avoidance
paradigm, we expected there would be no significant difference in the time to leave the dark chamber
between CO2 and isoflurane, but we expected a significant difference in the time to leave the dark
chamber between naïve rats and previously exposed rats.
2. Materials and Methods
2.1. Ethical Statement
All procedures were reviewed and approved by the Indiana University School of Medicine IACUC
prior to initiation of the project. The program is accredited by AAALAC International and compliant
with all applicable federal regulations.
2.2. Husbandry
As justified in Améndola and Weary [4], a sample size of 8 animals is necessary to observe treatment
differences. Based on previous work in our laboratory and others, we estimated a mean behavioral
relative frequency of 4.75 versus 4.25, with a standard deviation of 0.6. With a power of 0.8 and an
alpha of 5%, the calculated sample size was 12 animals to account for individual differences. All rats
were pair-housed in standard rat shoebox caging on an individually ventilated caging (IVC) system
rack (Lab Products, Seaford, DE, USA). The cages were bedded with pine chip bedding (Sani-Chip,
PJ Murphy Forest Products, Montville, NJ, USA) and nesting material (for enrichment), and each
cage was changed weekly. Food (Teklad 2018SX, Envigo, Indianapolis, IN, USA) was provided
without restriction. Reverse-osmosis-treated water was provided without restriction through an
automatic watering system. Cages were changed at least weekly in a laminar flow workstation (NuAire,
Plymouth, MN, USA) and were autoclaved prior to reuse. Hands and implements were disinfected
with MB10 (Quip Labs, Wilmington, DE, USA) between cages. The macroenvironment was on a 12:12-h
light:dark cycle (lights on, 07:00 h), and the temperature was maintained at 72 ± 1 ◦F (22.2 ◦C ± 0.5 ◦C),
with humidity maintained between 30% and 70%. The colony was screened quarterly by using indirect
sentinels. At the time of the study, the colony was free of the following pathogens: coronavirus
(sialodacryoadenitis virus), parvoviruses (NS1, rat pneumonia virus, Kilham rat virus, H1 virus,
rat minute virus), theliovirus, Clostridium piliforme, Mycoplasma pulmonis, pinworms (Aspicularis
tetraptera, Syphacia spp.), and fur mites (Radfordia ensifer, Ornithonyssus bacoti).
2.3. Experiment 1: Forced Exposure
2.3.1. Apparatus
All trials were performed in an acrylic glass cage (23 × 45 × 24 cm/24.84 L) with aspen chip
bedding (Teklad 7090, Envigo, Indianapolis, IN, USA). The cage was covered with an acrylic glass lid
that contained a gas inlet and an air outlet on the right side (11.25 × 5.75 cm from the corner of the box,
11.5 cm from each other), and a metallic tea ball (3 in. diameter) on the left side (Figure 1). CO2 was
delivered into the cage using compressed gas cylinders through a clear vinyl tube inserted in the gas
inlet. A flow meter connected to the compressed cylinder was used to regulate gas flow. Isoflurane
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and oxygen were delivered using a precision vaporizer through a clear vinyl tube inserted in the gas
inlet. Passive scavenging was used. Gas concentrations were not monitored to confirm distribution.
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2.3.2. Experimental Design
As in A éndola and Weary [4], twelve adult (ranging from 180 to 217 days of age) female
Sprague–Dawley rats were exposed during four consecutive days, once to each of four treatments:
isoflurane gradual-fill (3% in O2; 14% chamber vol. min−1), CO2 gradual-fill (18.5% chamber vol.
min−1), oxygen gradual-fill (O2; 14% chamber vol. min−1; control), and fox scent (5 µL fox urine
scent placed on a tissue paper and placed in a 3 in. diameter tea ball; passive response eliciting
stimulus). Our rationale in using 3% isoflurane gradual-fill in O2 (14% chamber vol. min−1) was
to enable exposure for the full testing period without the rats becoming unconscious, and is in line
with previous studies [26–28]. These rats were first generation offspring produced by breeder pairs
of Sprague–Dawley rats (Crl:CD; Charles River Laboratories, Wilmington, MA, USA). The breeder
pairs and their offspring were raised under variable light conditions for a separate study. Pups were
removed from the variable light conditions upon weaning (approximately 21 to 25 days of age) and
were housed with no further experimental manipulation until commencement of this study. Each rat
in each group was individually marked (1, 2, 3, or 4) on the tail with a permanent marker based on the
initial order of exposure. Order of exposure was allocated using three 4 × 4 Latin squares (four rats
and four treatments: CO2, oxygen, isoflurane, and fox scent). Three days after exposure to all four
treatments, the same twelve rats were re-exposed to the treatments, allocating treatment order in three
different 4 × 4 Latin squares (Table S1).
2.3.3. Testing Procedure
As in Améndola and Weary [4], rats were individually placed in the experimental cage covered
with the lid and remained there for 5 min to acclimate. Following this period, the rat was exposed to
the treatment for 2 min. For the fox scent treatment, the tea ball containing filter paper with 5 µL of fox
scent was attached during the experimental period. For CO2, isoflurane, and oxygen treatments, the
tea ball attached during the experimental period was empty. After the tea ball was in place, the gas
flow was started. Tests were stopped when the animal became ataxic or after 2 min, whichever came
first. Ataxia was defined as when the ani al started to have difficulty walking and started to fall on its
side (but could still right itself) and was al ays identified by the same observer. Our intention was
to stop before the animal reached the loss-of-righting-reflex stage. After each test, the experimental
cage and lids were cleaned with Rescue (Virox Animal Health, Oakville, OH, USA) and bedding was
replaced. All trials were performed under white light between 12:00 and 16:00 h.
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2.3.4. Behavioral Observations
Forced exposure trials were video recorded. As in Améndola and Weary [4], the videos were
divided into baseline (60 s before any test) and active periods (first 60 s of the test). These two periods
were scored for a total of 120 s. The frequency of active and passive behaviors (Table 1) were recorded
by an observer who was blinded to treatment. Total time spent on either side of the experimental cage
(tea ball or gas inlet) was also recorded.
Table 1. Descriptions of the behaviors assessed in Experiment 1 (Forced Exposure).
Active Behaviors
a. Rearing: raising the upper body on the hind limbs in a vertical position with
both front paws off the ground (frequency)
b. Line-crossing: Horizontal locomotor activity that results in the rat’s forepaws
crossing a line that divides the length of the chamber in half (frequency)
c. Lid-pushing: Push at the cage lid with nose or front paws (frequency)
d. Bedding manipulation: Displacement (pushing, shoveling, flicking,
or digging) of bedding material with front and/or back paws (frequency)
e. Grooming: Self-grooming using front paws to rub the face or ears (frequency)
f. Nose-touching: Aggressively sniffing the air outlet or the corners of the
testing apparatus (frequency)
Passive Behaviors
a. Immobility time: Absence of movement, except for small and slow lateral
movements of the head (seconds)
Other Measurements Time spent on either side of the cage (seconds)
2.3.5. Expected Outcomes
We hypothesized that we would observe statistically significant increases in active behaviors for
the rats exposed to CO2 and isoflurane, but not oxygen or fox urine. Minimal response was expected
with fox urine based on Améndola and Weary [4]. We also hypothesized that there would be no
significant difference in the active and passive behaviors between the CO2 and isoflurane groups.
2.4. Experiment 2: Aversion-Avoidance
2.4.1. Apparatus
The apparatus consisted of a plastic light–dark box consisting of two compartments (43.2 × 34.0 ×
19.8 cm each), connected by a small red buffer compartment (10 × 14 × 30 cm). The light compartment
was covered with white plastic on the sides and illuminated by two bulbs placed above the lid. The light
intensity was measured to be 3920 Lux at the bottom of the compartment. The dark compartment
was covered with a layer of red plastic and a layer of black plastic. The light intensity was measured
to be 85 Lux at the bottom of the compartment. Both compartments contained bedding. Doorways
of the buffer compartment were covered with black plastic flaps. The light and dark compartments
of the light-dark box were covered with plastic lids. The lid contained a gas inlet in the upper-left
and upper-right corner of the light and dark compartments (10.8 × 8.5 cm from the corner of the box)
respectively as seen in Figure 2. The lid corresponding to the dark compartment was covered with a
layer of red plastic and a layer of black plastic. Oxygen and isoflurane flow were regulated using a flow
meter integrated in an anesthetic machine. CO2 flow was regulated using a flow meter and delivered
from a compressed gas cylinder. All gases were delivered through a clear vinyl tube inserted in the gas
inlets. Passive scavenging was used. Gas concentrations were not monitored to confirm distribution.
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2.4.2. Habituation and Training
Rats were habituated to the light–dark box over two consecutive days. Each subject was placed in
the light compartment of the apparatus and left to explore for 30 min. On the second day, oxygen gas
(12% chamber vol. min−1) was delivered in both compartments.
2.4.3. Experimental Design
A total of 24 naïve female Sprague–Dawley rats and 12 rats from Experiment 1 were used
(total n = 36). One group of naïve rats (n = 12) was exposed twice to CO2 gradual-fill (approximately
19% displacement of chamber volume min−1) over two consecutive days. A second group of naïve rats
(n = 12) was exposed twice to isoflurane gradual-fill (3% in O2; 12% chamber vol. min−1) over two
consecutive days. A third group of rats (n = 6) from Experiment 1 was exposed twice to isoflurane
gradual-fill (3% in O2; 12% chamber vol. min−1) over two consecutive days and then twice to CO2
gradual-fill (approximately 19% displacement of chamber volume min−1) over two consecutive days.
A fourth group of rats (n = 6) from Experiment 1 was exposed twice to CO2 gradual-fill (approximately
19% displacement of chamber volume min−1) over two consecutive days and then twice to isoflurane
gradual-fill (3% in O2; 12% chamber vol. min−1) over two consecutive days (Table S2).
2.4.4. Testing Procedure
As in Améndola and Weary [4], rats were individually placed in the light compartment of the
light–dark box and allowed to explore the apparatus for 30 min with oxygen gas (12% chamber
vol. min−1) flowing to both compartments. We anticipated that all subjects would settle down in the
dark compartment for at least 10 min by the end of the 30 min acclimation period. CO2 or isoflurane
flow was then started in the dark compartment depending on the treatment group. The test was
stopped when the rat indicated intention to move into the light compartment (i.e., both shoulders
crossed from the dark compart ent into the buffer compartment) or if the rat was not recumbent
by 300 s from the start of gas flow. No specific steps were taken to randomize the order of testing.
The data were collected over time and at least two different treatment groups were initiated on each
day to create pseudo randomization. The time to leave the dark chamber (in seconds) was recorded
as the dependent variable. The light–dark box was disinfected using Rescue and the bedding was
replaced after each trial.
2.4.5. Expected Outcomes
The time to leave the dark chamber was compared between treatment groups. We hypothesized
that there would be no significant differences in the time to leave the dark chamber between the
isoflurane and CO2 treatment groups. We als expected a significant difference in time to leave the
dark chamber betw e the naïve rats and rats that had previous exposure to isofluran and CO2.
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2.5. Data Analysis
Analysis was performed using JMP Pro 15 software (SAS, Cary, NC, USA).
2.5.1. Analysis for Experiment 1: Forced Exposure
As in Améndola and Weary [4], rat responses were compared between treatment groups.
Two behaviors (nose touches and bedding manipulations) were not analyzed due to their infrequency,
which greatly skewed the data and increased the possibility of erroneous findings. Relative frequencies
of active and passive behaviors were used as response variables. Relative frequency of behaviors
was calculated by dividing the frequency of the behavior by time scored. Three models were used to
compare these rat responses: baseline, active, and change from baseline. Within each model, the effect
of treatment group and day of exposure (exposure vs. re-exposure) was investigated. The baseline data
between the conditions were compared between the treatments to ensure that there was no significant
difference as the rats were not being exposed to any treatment. The active data were compared between
the treatments to identify the effect of treatment on the behaviors. Change from baseline (relative
frequency of behavior in active period − relative frequency of behavior in baseline period) was also
investigated for each behavior to compare results with Améndola and Weary [4]. First, normality of
data and homogeneity of variance was determined using the Anderson–Darling test and Levene’s
test, respectively. For the baseline data, homogeneity of variance was satisfied but the data were
not normally distributed. For this reason, the Kruskal–Wallis test was applied to the baseline data.
For the active and change from baseline data, both normality of data and homogeneity of variance were
not satisfied, so Welch’s ANOVA was applied to investigate overall effects. Post-hoc Games–Howell
analysis was performed to investigate specific differences between groups.
2.5.2. Analysis for Experiment 2: Aversion-Avoidance
Three models were used with time to leave the dark chamber as the response variable. The first
model compared the effect of treatment group (previously exposed vs. naïve), treatment (CO2 vs.
isoflurane), and the interaction between treatment group and treatment. The second model investigated
the effect of order of exposure (i.e., CO2 first, isoflurane second vs. isoflurane first, CO2 s) in the
previously exposed group. The third model investigated the effect of day of exposure (exposure vs.
re-exposure) in the naïve group for isoflurane and CO2. The third model was not applied to data from
the forced exposure group because they had been previously exposed to both isoflurane and CO2.
First, normality of data and homogeneity of variance was determined using the Anderson–Darling
test and Levene’s test, respectively. Homogeneity of variance was satisfied for the CO2 treatment
group but not for the isoflurane treatment group. The data were also not normally distributed.
The data were further examined by computing the residuals for each group (FE/CO2; FE/isoflurane;
Naïve/CO2; Naïve/isoflurane) and testing normality of the residuals and homogeneity of variance
of the residuals. Residuals were calculated by subtracting the mean of the response variable for
each group from each observation within the group. Homogeneity of variance was satisfied for the
residuals of the CO2 treatment group but not for the isoflurane treatment group. The residual data
were also not normally distributed. A natural log (ln) transformation was performed to make the
data fit the assumptions of normality of data and homogeneity of variance. As before, normality of
data and homogeneity of variance was determined using the Anderson–Darling test and Levene’s
test, respectively. Both assumptions were satisfied in the ln-transformed data. Normality of data and
homogeneity of variance were also satisfied for the residuals of the ln-transformed data. Repeated
measures ANOVA (standard least squares with effect screening) was performed on the ln-transformed
data to investigate overall effects as there were two nominal variables. A one-way ANOVA was
performed to investigate the effect of treatment group (previously exposed vs. naïve) within each
treatment (CO2 vs. isoflurane).
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3. Results
3.1. Forced Exposure
3.1.1. Baseline Data
There were no significant differences between treatment groups for rears (degrees of freedom
(df) = 3; H = 0.2971; p = 0.9606), line crosses (df = 3; H = 1.9967; p = 0.5731), time immobile (df = 3;
H = 0.7877; p = 0.8524), time by gas inlet (df = 3; H = 1.8928; p = 0.5950), and time by tea ball (df = 3;
H = 1.8928; p = 0.5950).
3.1.2. Active Data
The active behavior data are summarized in the table below (Table 2). For rears, there was a
statistically significant difference between treatment groups (Table 2). Post-hoc analysis showed a
significant difference between CO2 and fox urine (p = 0.0331), isoflurane and fox urine (p = 0.0043),
and isoflurane and oxygen (p = 0.0304). On initial exposure, there was no significant difference between
treatment groups (df = 3, 22.795; F = 1.2221; p = 0.3244), but there was a significant difference between
treatment groups on re-exposure (df = 3, 23.399; F = 6.8836; p = 0.0017). Post-hoc analysis showed a
significant difference between CO2 and fox urine (p = 0.0216) and isoflurane and fox urine (p = 0.0037)
on re-exposure.
Table 2. Data from the active period (during exposure to treatment). F ratios and p values are reported
for main effects with significance set at p < 0.05. An asterisk (*) signifies when the p value is significant.
Data are reported as mean relative frequency ± standard deviation [95% CI].
Behaviors
F Ratio [df];
p Value
Mean Relative Frequency ± Standard Deviation [95% CI]
CO2 Fox Urine Isoflurane Oxygen
Rears 6.2068 [3, 49.07];0.0012 *
0.109 ± 0.074
[0.077, 0.140]
0.057 ± 0.044
[0.037, 0.077]
0.102 ± 0.038
[0.085, 0.118]
0.064 ± 0.051
[0.042, 0.086]
Line crosses 7.1582 [3, 49.494];0.0004 *
0.057 ± 0.032
[0.044, 0.071]
0.025 ± 0.026
[0.013, 0.036]
0.032 ± 0.022
[0.022, 0.041]
0.018 ± 0.027
[0.007, 0.030]
Immobility time 3.2660 [3, 49.271];0.0290 *
0.366 ± 0.246
[0.262, 0.470]
0.535 ± 0.332
[0.386, 0.681]
0.364 ± 0.251
[0.258, 0.470]
0.562 ± 0.298
[0.436, 0.688]
Time by gas inlet 0.8066 [3, 48.648];0.4964
0.414 ± 0.230
[0.317, 0.512]
0.440 ± 0.357
[0.265, 0.582]
0.527 ± 0.285
[0.407, 0.647]
0.470 ± 0.385
[0.307, 0.633]
Time by tea ball 0.8013 [3, 48.647];0.4992
0.585 ± 0.230
[0.487, 0.682]
0.557 ± 0.356
[0.416, 0.732]
0.472 ± 0.285
[0.352, 0.592]
0.529 ± 0.387
[0.366, 0.693]
For line crosses, there was a statistically significant difference between treatment groups (Table 2).
Post-hoc analysis showed a significant difference between CO2 and oxygen (p = 0.0003), CO2 and fox
urine (p = 0.0027), and CO2 and isoflurane (p = 0.0149). There was a significant difference between
groups on initial exposure (df = 3, 23.023; F = 5.3925; p = 0.0058) and on re-exposure (df = 3, 23.75;
F = 4.0182; p = 0.018). Post-hoc analysis showed a statistically significant difference between CO2 and
oxygen (p = 0.0047) on initial exposure, and CO2 and fox urine (p = 0.0126) on re-exposure.
For immobility time, there was a statistically significant difference between treatment groups
(Table 2). Post-hoc analysis did not show a statistically significant difference between CO2 and oxygen
(p = 0.0780), and isoflurane and oxygen (p = 0.0757). There was no significant difference between
groups on initial exposure (df = 3, 23.638; F = 0.5655; p = 0.6431), but there was a significant difference
between groups on re-exposure (df = 3, 23.014; F = 3.9085; p = 0.0216). Post-hoc analysis showed a
significant difference between CO2 and oxygen (p = 0.0330) on re-exposure. There was no significant
difference between treatment groups (Table 2) for time spent by the gas inlet and for time spent by the
tea ball.
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3.1.3. Change from Baseline Data
The change from baseline data are summarized in the table below (Table 3). For rears, there was
a statistically significant effect of treatment group (Table 3). Post-hoc analysis did not show any
significant difference between groups on initial exposure, but there was a significant difference between
CO2 and fox urine (p = 0.0492) and isoflurane and fox urine (p = 0.0154) on re-exposure. For line
crosses, there was no statistically significant effect of treatment group (Table 3). Post-hoc analysis did
not show any significant difference between groups on initial exposure, but there was a significant
difference between CO2 and fox urine (p = 0.0319) on re-exposure.
Table 3. Change from baseline data. F ratios and p-values are reported for main effects with significance
set at p < 0.05. An asterisk (*) signifies when the p-value is significant. Data are reported as mean
relative frequency ± standard deviation [95% CI].
Behaviors
F Ratio [df];
p-Value
Mean Relative Frequency ± Standard Deviation [95% CI]
CO2 Fox Urine Isoflurane Oxygen
Rears 4.7473 [3, 48.556];0.0056 *
0.019 ± 0.095
[−0.020, 0.059]
−0.025 ± 0.039
[−0.042, −0.008]
0.015 ± 0.044
[−0.003, 0.034]
−0.025 ± 0.073
[−0.057, 0.005]
Line crosses 2.3571 [3, 49.497];0.0830
0.024 ± 0.048
[0.003, 0.044]
−0.007 ± 0.039
[−0.024, 0.010]
0.0006 ± 0.033
[−0.013, 0.014]
−0.006 ± 0.040
[−0.023, 0.009]
Immobility time 2.6673 [3, 49.678];0.0578
−0.066 ± 0.365
[−0.220, 0.088]
0.145 ± 0.301
[0.011, 0.278]
0.003 ± 0.274
[−0.112, 0.119]
0.172 ± 0.341
[0.028, 0.316]
Time by gas inlet 0.0850 [3, 49.955];0.9679
0.002 ± 0.276
[−0.114, 0.118]
−0.033 ± 0.246
[−0.143, 0.075]
−0.021 ± 0.317
[−0.155, 0.112]
−0.032 ± 0.295
[−0.157, 0.092]
Time by tea ball 0.0810 [3, 49.955];0.9700
−0.002 ± 0.276
[−0.118, 0.114]
0.032 ± 0.248
[−0.077, 0.142]
0.021 ± 0.317
[−0.112, 0.155]
0.032 ± 0.296
[−0.092, 0.157]
For immobility time, there was no statistically significant difference between treatment groups
(Table 3). Post-hoc analysis did not show a significant difference between treatment groups on initial
exposure or re-exposure. For time by gas inlet, there was no significant difference between treatment
groups (Table 3). Post-hoc analysis did not show a significant difference between groups on initial
exposure or re-exposure. For time by tea ball, there was no significant difference between treatment
groups (Table 3). Post-hoc analysis did not show a significant difference between groups on initial
exposure or re-exposure.
3.2. Aversion-Avoidance
The data in Table 4 show an overall statistical significance in time to leave the dark chamber
between the treatment groups and previous exposure to the gases (df = 3, 91; F = 4.6531; p = 0.0045).
There was no significant interaction of the treatment group and whether the animals had been
previously exposed to CO2/isoflurane (i.e., animals from the forced exposure experiment) on time to
leave the dark chamber (Table 4). There was a statistically significant difference between the forced
exposure groups (meaning they had been previously exposed to both isoflurane and CO2) and the
naïve group (Table 4). The naïve group (Mean: 103.3 s; 95% CI: 82.9 to 128.6) stayed in the dark
chamber for a longer time compared to the forced exposure group (Mean: 69.72 s; 95% CI: 56.0 to
87.2) overall. There was also a statistically significant effect of the treatment group on time to leave
the dark chamber (Table 4). Animals in the CO2 group (Mean: 69.42 s; 95% CI: 55.7 to 86.4) stayed in
the dark chamber for a shorter time than the animals in the isoflurane group (Mean: 104.64 s; 95% CI:
83.3 to 129.8) overall. In the forced exposure group, there was no statistically significant effect of order
of exposure (CO2 first vs. isoflurane first) on time to leave the dark chamber when exposed to CO2
(df = 1, 22; F = 0.1012; p = 0.7534) or isoflurane (df = 1, 21; F = 2.0309; p = 0.1688). Within the naïve
group, there was no statistically significant effect of day of exposure on time to leave the dark chamber
for isoflurane (df = 1, 22; F = 0.3883; p = 0.5396) or CO2 (df = 1, 22; F = 0.0169; p = 0.8978). There was
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no significant difference in time to leave the dark chamber between the CO2 and isoflurane exposures
for rats previously exposed to both agents (df = 1, 45; F = 1.0675; p = 0.3070).
Table 4. Data from the aversion-avoidance experiment. F ratios and p values are reported for main
effects with significance set at p < 0.05. An asterisk (*) signifies when the p value is significant. Data are
reported as mean (in seconds) [95% CI].
Groups F Ratio [df]; p-Value Mean (in Seconds) [95% CI]
Forced Exposure (FE) or Naïve 6.1998 [1, 93]; 0.0146 *
FE Naïve
69.72 [56.0, 87.2] 103.30 [82.9, 128.6]
Treatment 6.6565 [1, 93]; 0.0115 *
CO2 Isoflurane
69.42 [55.7, 86.4] 104.64 [83.3, 129.8]
Forced Exposure (FE) or Naïve
interaction with Treatment
0.9614 [3, 93]; 0.3294
FE, CO2 FE, Isoflurane
61.67 [45.2, 84.0] 78.14 [57.3, 106.5]
Naïve, CO2 Naïve, Isoflurane
79.25 [57.7, 108.7] 136.57 [100.1, 186.1]
The data were further analyzed within each treatment (CO2 vs. isoflurane) and group (forced
exposure vs. naïve) using a one-way ANOVA (Figure 3). There was no statistically significant difference
(df = 1, 46; F = 1.0160; p = 0.3187) in time to leave the dark chamber between the forced exposure
group and naïve group when exposed to CO2. When exposed to isoflurane, there was a statistically
significant difference in time to leave the dark chamber between the forced exposure group and the
naïve group (df = 1, 45; F = 6.8986; p = 0.0117). There was no significant difference in time to leave the
dark chamber between the CO2 and isoflurane exposures for rats previously exposed to both agents
(df = 1, 45; F = 1.0675; p = 0.3070). However, there was a significant difference in time to leave the dark
chamber between the CO2 and isoflurane exposures for naïve rats (df = 1, 46; F = 7.8289; p = 0.0075).
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4. Discussion
4.1. Forced Exposure
4.1.1. Baseline Data
We did not expect any significant differences between the treatment groups during this period
because the rats were not being exposed to any treatment. Our data match this prediction.
4.1.2. Active Data
For the active period, we expected that the isoflurane and CO2 treatments would show significantly
higher relative frequencies of active behaviors when compared with the fox urine and oxygen treatments.
For rears, we observed a significant increase when comparing CO2 and fox urine, isoflurane and fox
urine, and isoflurane and oxygen. This matches with our initial prediction. A significant increase in
rearing during CO2 exposure compared to the control group has been previously observed by Niel
and Weary [7], but other studies [8–10] have failed to observe this trend. Moreover, our results show
a significant increase in rearing during isoflurane exposure compared to the control groups, which
has not been observed in previous studies [8,10]. This increase was significant during re-exposure
between CO2 and fox urine, and isoflurane and fox urine. This indicates that both isoflurane and CO2
elicit an increase in rearing during re-exposure, which could be interpreted as an attempt to escape
gas exposure.
For line crosses, we observed a significant increase when comparing CO2 with oxygen, isoflurane,
and fox urine. This increase was significant between the CO2 group and the control groups during
both initial exposure and re-exposure. These results are consistent with a previous study [7] that found
an increase in line crossing for CO2 when compared to air. Like rearing, this could be interpreted as an
attempt to escape gas exposure in rats exposed to CO2. Clearly, in this case, CO2 elicited a different
behavioral response when compared to isoflurane.
Moreover, there was a significant decrease in immobility time during re-exposure when comparing
CO2 and oxygen. Rats exposed to CO2 and isoflurane spent more time compared to the control groups
in active behaviors such as rearing and line crossing, so it logically follows that there would be a
difference in immobility time between groups. The increase in active behaviors for the CO2 and
isoflurane groups was expected because the gases cause agitation and can be interpreted as an effort
by the animal to escape the gas. An increase in active behaviors would mean less time was spent
immobile, which also is consistent with the data as there was a significant difference in immobility time
between the groups. An interesting behavioral observation is that there was no significant difference
in the time spent on either side of the apparatus. It was expected that the animals would spend less
time near the source of the gas if it were aversive. However, it is possible that they could not escape
the gas within the chamber as the apparatus was small, which could have led to the gas distributing
equally in the chamber during the exposure period. Thus, there was no advantage to being on either
side of the chamber, and the animals tried to actively escape the aversive stimulus by searching for
escape routes on either side of the cage, leading to equal time spent on either side of the cage. We did
not measure the distribution of gases due to the logistical issues with measuring distribution in the fox
urine and isoflurane treatments, but movement of the animal would have caused the gas to distribute
equally in the apparatus during the exposure period.
4.1.3. Change from Baseline Data
For rears, there was a significant effect of treatment group. The relative frequency of rears was
significantly higher during re-exposure between CO2 and fox urine, and isoflurane and fox urine.
This difference between CO2 and fox urine on re-exposure is consistent with the data from Améndola
and Weary [4]. However, Améndola and Weary [4] observed this difference during initial exposure to
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CO2 as well, which was not observed in this study. Possible reasons for the differences between this
study and Améndola and Weary [4] are discussed later in the Comparisons section of the discussion.
For line crosses, we did not observe a significant effect of treatment group. We did not observe
any difference between groups on initial exposure, but there was a significant increase in line crosses
between CO2 and fox urine on re-exposure. While the latter statement is consistent with results
from Améndola and Weary [4], the former is not. Améndola and Weary [4] also observed an overall
significant effect of treatment group on line crossing behavior, which was not observed in this study.
For immobility time, we did not observe a significant effect of treatment group. We did not observe
any effect of exposure number (exposure vs. re-exposure) on immobility time between treatment
groups either. Again, this result conflicts with data from Améndola and Weary [4], who observed
a significant difference in immobility time between CO2 and fox urine, and CO2 and oxygen on
re-exposure. There was a large standard error in this behavior, which could be attributed to individual
variation within groups. This indicates that there is individual variation in sensitivity when exposed to
CO2, fox urine, isoflurane, and oxygen, as evidenced by Améndola and Weary [4].
There was no significant difference in time spent on either side of the apparatus for any of the
treatment groups. Again, there was high variation for this variable, and this could be attributed
to individual differences between the animals. This result suggests that the rats did not attempt to
actively avoid the location for the entry point of the anesthetic/control agent. As discussed previously,
this could be because the small size of the chamber and because the movement of the rat enabled equal
distribution of the gas in the chamber, thus creating no advantage of being away from the gas inlet.
4.2. Aversion-Avoidance
4.2.1. Between Treatment Groups
In the aversion-avoidance experiment, there was an overall significant effect of treatment group
and previous exposure to the gases on the time to leave the dark chamber. Rats with previous
exposure to CO2 and isoflurane left the dark chamber significantly earlier when compared to naïve
rats. This finding suggests that previous exposure to anesthetic gases can lead to increased aversion
during re-exposure. Moreover, there was a significant effect of treatment group on time to leave the
dark chamber. Rats in the CO2 group stayed in the dark chamber for a shorter time when compared to
the isoflurane group. This finding indicates that CO2 is possibly more aversive to rats than isoflurane
overall. There is a stark difference in the average time to leave the dark chamber during CO2 exposure
when comparing the results of this study with those obtained by Améndola and Weary [4]. The rats in
their study (which had been previously exposed in their forced exposure experiment) stayed in the
dark chamber for an average of 35 s during initial exposure and 33 s on re-exposure. On the other hand,
the rats in our study stayed in the dark chamber for an average of 61.67 s when previously exposed
and 79.25 s when naïve. The possible reasons for this difference are discussed later in the Comparisons
section of the discussion.
4.2.2. Within Treatment Groups
Rats in the CO2 group left the dark chamber earlier than the rats in the isoflurane group when
the animals were naïve to both gases. However, there was no significant difference in the time to
leave the dark chamber between CO2 and isoflurane for the rats with previous exposure to the gases.
This is consistent with a recent study [13] which showed that isoflurane and CO2 are similarly aversive
to mice. Based on this data, the use of isoflurane as an anesthetic prior to euthanasia with CO2 is
not a refinement if the rats have been previously exposed to isoflurane. In fact, some studies [23,25]
have shown that there is a generalized learned aversion to halogenated anesthetics (e.g., isoflurane,
halothane) in rats, which means that prior use of halogenated anesthetics could result in distress to the
animal if isoflurane is used during euthanasia procedures. The mechanism by which this generalized
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aversion develops is not well-characterized, and it is also not known if this generalized aversion is
sustained in the days after exposure to halogenated anesthetics.
Furthermore, within the CO2 group, there was no significant difference between rats previously
exposed to CO2 and rats that were naïve to CO2. This suggests that CO2 was not more aversive
on re-exposure. However, within the isoflurane group, naïve rats stayed in the dark chamber for
significantly longer when compared to rats previously exposed to isoflurane. This is consistent with
previous studies that indicate a component of learned aversion in exposure to isoflurane [24,25].
Some researchers [13,25] contend that this aversion to isoflurane is transient, and is not sustained in
the days after exposure, thus eliminating the idea that use of isoflurane during procedures requiring
anesthesia has an impact on the use of isoflurane during euthanasia. However, a recent study [29]
found this learned aversion to isoflurane is maintained for up to 7 days after initial exposure to
isoflurane. Our study builds on this data. We re-exposed rats from the forced exposure experiment
to isoflurane during the aversion-avoidance experiment at least 15 days after their first exposure to
isoflurane in the former experiment. Our results found that rats that had been previously exposed to
isoflurane left the dark chamber significantly earlier when compared to naïve rats during exposure to
isoflurane. If the effects of learned aversion were transient, there would not be a difference between
these two groups. Thus, our study shows that aversion to isoflurane is sustained for at least 15 days
after initial exposure to isoflurane. Given this finding, we would not recommend the use of isoflurane
for euthanasia if there has been prior exposure of the rat to isoflurane. Repeat use of isoflurane should
probably also be avoided, if possible, given the sustained aversion associated with this anesthetic agent,
though the length of time that this learned aversion is sustained is worthy of an additional study.
Moreover, while the data did not show a statistically significant effect of day of exposure (exposure
vs. re-exposure) on latency to leave the dark chamber in naïve rats, it is possible that the rats did
not fully acclimate to this treatment as illustrated by the learned aversion to isoflurane in the forced
exposure group. The lack of a statistically significant effect of day of exposure on time to leave the dark
chamber for naïve rats when exposed to CO2 is consistent with results from Améndola and Weary [4].
4.3. Comparisons
There are several ideas that could explain the differences in results between this study and the
study performed by Améndola and Weary [4]. Firstly, the stock/strain difference could account for
the difference in sensitivity to the agents used [1,30–34]. This study used first generation offspring
from Sprague–Dawley rats obtained from Charles River laboratories, while Améndola and Weary [4]
used surplus Sprague–Dawley animals from the University of British Columbia, but did not provide
information regarding the original source of these animals. Previous studies [35,36] have shown that
there is an effect of sub-strain (vendor) on rodent behavior. Sub-strains of C57BL/6 mice from Charles
River Laboratories (C57BL/6Crl) and Jackson Laboratory (C57BL/6J) differ significantly in their alcohol
consumption behaviors. C57BL/6J mice show a significantly higher ethanol preference compared to
C57BL/6Crl mice [35], but C57BL/6Crl mice show a robust ethanol deprivation effect (EDE) that is
not observed in C57BL/6J mice [36]. A careful understanding of the source of the animals used in an
experiment is critical to the validity of the claims made because of the experiment, due to the effect that
genetic drift and differences in microbiome, among other biological differences, could have on rodent
behavior. Therefore, it is possible that vendor sub-strain differences contributed to the discrepancies in
the results between our study and that performed by Améndola and Weary [4]. Studies [30,34] have
also shown an effect of strain on rodent behavior. Britt [34] demonstrated a difference in response to
CO2 exposure between Sprague–Dawley and Lister-Hooded rats. Sprague–Dawley rats tended to
become more active as CO2 concentrations increased while Lister-Hooded rats tended to spend more
time immobile. Moreover, Creamer-Hente et al. [30] evaluated four strains of male and female mice
and their stress responses to CO2 euthanasia. They observed a statistically significant effect of strain
on duration of ataxia and labored breathing. These studies suggest that strain identity could play an
important role on behaviors associated with aversion or effort to escape such as rearing, grooming,
Animals 2020, 10, 1431 14 of 18
and line crossing. It is necessary to consider the effect of strain and sub-strain when making blanket
claims on the effects of CO2 exposure in rodents. Consequently, tailoring of euthanasia guidelines
depending on these factors may be necessary.
Additionally, previous exposure to bleach was a confounding variable in the study by Améndola
and Weary [4] that could explain the differences in sensitivity to treatments. The dose and length
of time that the rats were exposed to bleach were not provided, and it is known that bleach is an
irritant that can cause damage to the nasal mucosa [37]. It is possible that the responses between the
two studies differed because of the previous experimental manipulation of the rats in Améndola and
Weary [4].
Thirdly, even though both studies coded for the same behaviors in the forced exposure experiment,
there could be variation in each individual scorer and what they perceived each action as, for example,
a rear. Makowska and Weary [38] discuss a lack of consistency between scorers in observations of
gross behavior. Even though the definitions for behaviors scored were identical between our studies,
it is possible that borderline cases (where, for example, the behavior could be perceived as a rear or
not) could have differed between the observers. This perceptual difference is evidenced in Améndola
and Weary’s [4] score for inter-observer reliability, which was low for some behaviors such as line
crosses (r = 0.77) and bedding manipulations (r = 0.76), but higher for other behaviors such as rears
(r = 0.91) and immobility time (r = 0.99). It is important to note here that these scores for inter-observer
reliability are based on a small sample of the videos, and measuring inter-observer reliability between
two observers for all the videos could have led to lower r values. Future research could investigate
differences between observers when scoring the same behaviors based on definitions.
For the aversion-avoidance study, one difference between the two studies was in the definition of
the endpoint for when the rat “left” the dark compartment. Améndola and Weary [4] defined their
end-point for the aversion-avoidance experiment as when the rat crossed from the buffer compartment
to the light compartment. However, this study defined the end-point as when the rat crossed from
the dark compartment to the buffer compartment. Therefore, it would be expected that the time to
leave the dark chamber would be shorter in this study as compared to the study by Améndola and
Weary [4]. Crossing from the dark compartment into the buffer compartment indicated an intention to
leave the compartment. Because the buffer compartment had flaps, the rat could have settled in the
buffer compartment after leaving the dark compartment if the gas was not able to pass through the
buffer compartment, which is why we selected this endpoint, even though it is more conservative than
the previous study.
Moreover, there is a difference in light intensity in the light compartment between our study and
Améndola and Weary [4]. Their study used a light intensity of 1650 Lux while our study used a light
intensity of 3920 Lux. This difference in light intensity could explain the difference in the time to leave
the dark chamber values between the two studies. Lastly, the rats in the Améndola and Weary [4] study
were previously exposed to CO2 in the forced exposure paradigm, which could have confounded their
results in the following approach-avoidance and aversion-avoidance studies because the rats were no
longer naïve [23].
4.4. Limitations and Future Research
One possible limitation in this study is that the ethogram scored was not as extensive as it could
have been. Behaviors like freezing, gasping, shaking, and recoil from sniffing of the gas tube are
possible behaviors that could be included in future studies investigating animal welfare focused
effects of CO2 and various halogenated anesthetics (such as isoflurane), though there is still much
discussion on which behaviors are the most relevant [39]. Behavioral assessment of stress responses
is strengthened with the inclusion of physiologic data, such as evaluation of the neuroendocrine
response [1,2].
Another possible limitation is that a male experimenter was present in sight and smell of the
animals used in this experiment, which has been shown [40] to cause physiological stress responses in
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rodents. This could have been a possible confounding effect in this study. There was also no formal
randomization of testing in the aversion-avoidance experiment, which could have introduced bias.
Moreover, our study and the study by Améndola and Weary [4] did not measure gas concentration in
various parts of the apparatus to confirm equal distribution. This could be a possible limitation in both
studies as it could be a confounding effect in the design of the study or in the interpretation of data.
Another limitation in both studies is the difference in the chamber volume displacement rates
between the different gases in both experiments (forced exposure and aversion-avoidance). In the
forced exposure experiment, we used a 14% chamber vol. min−1 displacement rate for isoflurane
and oxygen, and an 18.5% chamber vol. min−1 displacement rate for CO2. Améndola and Weary [4]
used a 16.2% chamber vol. min−1 displacement rate for oxygen and an 18.5% chamber vol. min−1
displacement rate for CO2. Similarly, in the aversion-avoidance experiment, we used a 12% chamber
vol. min−1 displacement rate for isoflurane and oxygen, and a 19% chamber vol. min-1 displacement
rate for CO2. Améndola and Weary [4] used a 30.9% chamber vol. min−1 displacement rate for oxygen,
and a 19% chamber vol. min−1 displacement rate for CO2. The differences in the volume displacement
rates between groups and during habituation is a confounding effect in both studies that could have
impacted the dependent variables.
Future studies could investigate the intrinsic mechanisms through which learned aversion to
isoflurane is developed and the generalization of this aversion to other halogenated anesthetics
like halothane [25]. It is known that CO2 exposure causes hypercapnia (an increase in blood CO2
concentration) and acidosis (a decrease in blood pH), and that the human body responds to oppose
this change [41]. However, at a certain point, these responses are not sufficient and consequently, may
lead to the development of negative emotional states such as air hunger [42]. It is thought that this is
the primary cause of aversion to CO2 exposure in naïve rats. On the other hand, the mechanism of
action for isoflurane is not well-characterized. It is speculated that inhalant anesthetics like isoflurane
act by altering the activity of neuronal ion channels [43–45]. A recent study [46] found that isoflurane
and sevoflurane induced hyperglycemia in adult mice but hypoglycemia in neonatal mice. This is
consistent with other studies that have reported hyperglycemia in adult humans during induction
with isoflurane [47] and hypoglycemia and metabolic acidosis in neonatal mice [48]. These effects
could be linked to isoflurane’s mechanism of action.
Another important consideration in the clinical effect of anesthesia is that aversion during repeat
exposure to inhalant anesthetics involves a component of the animal’s experience during recovery while
aversion during initial exposure involves only the initial experience to the inhalant anesthetic. For this
reason, development of learned aversion may stem from the recovery process due to repeat exposure to
inhalant anesthetics and thus an understanding of the mechanism of action of halogenated anesthetics
such as isoflurane is necessary if there is an intention to attenuate the effect of learned aversion.
5. Conclusions
When placed in the forced exposure apparatus, rats were more active in the isoflurane and CO2
treatments compared to the control groups, suggesting that isoflurane and CO2 are similarly aversive.
The results from the aversion-avoidance apparatus supported previous work which demonstrated
that while CO2 is more aversive than isoflurane on initial exposure, rats demonstrate increased
aversion upon re-exposure to isoflurane. This effect of learned aversion is sustained for at least 15 days
after initial exposure to isoflurane. Given this result, we suggest that CO2 is superior to isoflurane
when euthanizing rodents with prior exposure to isoflurane. Overall, these results confirm previous
studies [25] which suggest that care should be taken when considering serial use of isoflurane as
an anesthetic.
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